课题基金 / 基金详情

Viral mutations and host diversities that contribute to hepatocarcinogenesis

Viral mutations and host diversities that contribute to hepatocarcinogenesis
导致肝癌发生的病毒突变和宿主多样性
批准号:
14570449
负责人:
KATO Naoya
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

KATO Naoya的其他基金

相似基金

相关文献

中文摘要
翻译
肝炎病毒感染的自然史包括慢性肝炎、肝硬化和肝细胞癌(HCC)。然而,影响疾病进展为HCC的因素尚未得到很好的阐明。在这里,我们研究了导致肝癌发生的病毒突变和宿主疾病。1)从1.000例获得书面知情同意书的13/C型肝炎患者血清中提取白细胞DNA,并建立包含这些患者临床资料的数据库。然后,我们建立的方法匿名500例患者的WBC DNA样本。2)通过对有无HOC患者的B型肝炎病毒(HBV)X基因核苷酸序列分析,发现HBx基因第38位密码子的氨基酸替换与HOC的发生密切相关。3)干扰素生物学应答者(BR)与干扰素非应答者(NR)相比,HCV核心C端疏水区氨基酸发生变化的频率更高。激活 ...更多信息 与NR组相比,BR组中干扰素治疗后核心蛋白介导的白细胞介素(IL)-8启动子的表达显著降低。HCV核心区氨基酸序列的差异可能通过调节HCV感染患者中IK-8的诱导而与肝炎活动性相关。4)测定HCV核心蛋白、HBx蛋白和丁型肝炎病毒大抗原对细胞内信号传导途径的影响。5)研究了280例日本慢性HCV感染患者(122例HCC)的尿苷5 '-二磷酸葡萄糖醛酸转移酶1A 7(UGT 1A 7)和1 L-1β的遗传多态性。HOC患者UCT 1A 7低活性等位基因(L)/L和高活性等位基因(H)/L的比例(分别为25%和45%)高于非HOC患者(分别为15%和39%),与UGT 1A 7 H/H相比,比值比分别为2.7和1.8。与C/C基因型相比,IL-1β/-31 T/T基因型与HOC的存在显著相关,比值比为2.9。6)为寻找HOC易感基因的单核苷酸多态性(SNPs),对376例日本慢性HCV感染患者(包括170例HOC患者)的172个候选基因的394个SNPs进行了检测。来自三个基因的三个SNP与HOC显著相关。这些SNPs和单倍型将被用作标记,以确定在日本慢性HCV感染患者中HOC风险较高的亚组。少
英文摘要
The natural history of hepatitis virus infection consists of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). However, the factors influencing disease progression to HCC have not been well elucidated. Here, we studied viral mutations and host diversities that contribute to hepatocarcinogenesis. 1) WBC DNAs were extracted from sera of 1.000 patients with hepatitis 13/C after obtaining written informed consent, and data base containing clinical data of these patients were constructed. Then, WBC DNA samples of 500 patients were anonymized by the method we established. 2) By analyzing hepatitis B virus (HBV) X gene nucleotide sequence in patients with/without HOC, it was revealed that amino acid substitution in codon 38 in HBx is significantly related with HOC. 3) Amino acid changes in C-terminal hydrophobic region of hepatitis C virus (HCV) core were observed more frequently in the interferon biological responders (BR) compared to interferon noivresponders (NR). Activatio … More n of Interleukin (IL)-8 promoter by core proteins significantly decreased after interferon therapy in the BR group compared to the NR group. Differences in amino acid sequence of HCV core possibly correlate with hepatitis activity by modulating IK-8 induction in HCV infected patients. 4) The effect of HCV core protein, HBx protein, and hepatitis delta virus large antigen on intracellular signaling pathway was determined. 5) Genetic polymorphsims of uidine 5'-diphosphate-glucuronosyltransferase 1A7 (UGT 1A7) and 1L-1β were investigated in 280 Japanese patients (122 with HCC) with chronic HCV infections. The proportions of UCT1A7 low activity allele (L)/L and high activity allel (H)/L in patients with HOC (25% and 45%, respectively) were higher than those in patients without HOC (15% and 39%, respectively) with an odds ratio of 2.7 and 1.8, respectively, comared with the UGT1A7 H/H. The IL-1β/-31 T/T genotype showed a significant association with the presence of HOC compared with the C/C genotype with an odds ratio of 2.9. 6) To search of single nucleotide polymorphisms(SNPs) for HOC susceptibility genes, 394 SNPs derived from 172 candidate genes were examined in 376 Japanese patients (including 170patients with HOC) with chronic HCV infection. Three SNPs derived from three genes were significantly associated with HOC. These SNPs and haplotypes will be used as markers to identify a subgroup at higher risk of HOC in Japanese patients with chronic HCV infection. Less
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
Kanda T, Kato N, et al.: "Hepatitis A virus VP3 may activate serum response element associated transcription."Scand J Gastroenterol. 38. 307-313 (2003)
Kanda T、Kato N 等人:“甲型肝炎病毒 VP3 可能激活血清反应元件相关转录。”Scand J Gastroenterol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wang Y et al.: "Interleukin-1β gene polymorphisms associated with nepatocellular carcinoma in hepattes C virus infection"Hepatology. 37. 65-71 (2003)
Wang Y等:“Interleukin-1β基因多态性与丙型肝炎病毒感染中的海细胞癌相关”Hepatology. 37. 65-71 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Goto T, Kato N, et al.: "Hepatitis B virus HBx and the large hepatitis Delta antigen synergistically activate the SRE-dependent pathway."J Infect Dis. 187. 820-828 (2003)
Goto T、Kato N 等人:“乙型肝炎病毒 HBx 和大肝炎 Delta 抗原协同激活 SRE 依赖性途径。”J Infect Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hara K, Kato N, et al.: "Establishment of a method of anonymization of DNA samples in genetic research."J Hum Genet. 48. 327-330 (2003)
Hara K、Kato N 等人:“遗传研究中 DNA 样本匿名化方法的建立。”J Hum Genet。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 23 条
    Interferon stimulated genes and its polymorphisms determining Hepatitis C virus replication and pathogenesis of hepatitis C
    • 批准号:
      20590760
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      KATO Naoya
    • 依托单位:
    Comprehensive analysis of hepatitis Cvirus protein that disturb host interferon system
    • 批准号:
      18590718
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.57万
    • 财政年份:
      2006
    • 负责人:
      KATO Naoya
    • 依托单位:
    Analyses of the individual risk for hepatocellular carcinoma by large scale search of single nucleotide polymorphisms of cytokine genes
    • 批准号:
      16590578
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2004
    • 负责人:
      KATO Naoya
    • 依托单位:
    Molecular mechanism of inflammatory cytokine induction by hepatitis viruses
    • 批准号:
      12670462
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2000
    • 负责人:
      KATO Naoya
    • 依托单位:
    国内基金
    海外基金
    RBM38基因SNP对人红细胞卟啉代谢的影响
    • 批准号:
      2025JJ81130
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      刘康
    • 依托单位:
    风险SNP介导的增强子通过FAM13A在哮喘 肺泡巨噬细胞中引发M1型炎症的机制研 究
    FST基因调控猪乳腺原基上皮细胞功能研究及其因果SNP位点鉴定
    • 批准号:
      2025JJ60129
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      刘晨曦
    • 依托单位:
    图表示学习的SNP模型研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郭平
    • 依托单位: